TCM
IHI icon

Triumph Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Triumph Capital Management’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$2.67K – 1888
2026
Q1 		$2.67K Sell
50
-210
-81% -$12.3K ﹤0.01% 1490
2025
Q4 		$16.2K Buy
+260
New +$16.1K ﹤0.01% 935

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Triumph Capital Management's IHI Position: Q2 2026 in Review

Triumph Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 50 shares — an estimated $2.67K sold.

Triumph Capital Management first reported a position in IHI in Q4 2025 and held it in 2 quarters. The position peaked at $16.2K in Q4 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Triumph Capital Management reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
  • Triumph Capital Management sold 50 iShares US Medical Devices ETF shares in Q2 2026, an estimated $2.67K.
  • Triumph Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2025 and held it in 2 quarters.
  • Triumph Capital Management's iShares US Medical Devices ETF position peaked at $16.2K in Q4 2025.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.